Fairness opinions › Acquirers
UnitedHealth Group: healthcare acquisitions with fairness opinions
3 public-company targets, 2019-2023, $11B combined enterprise value. The multiples UnitedHealth Group paid and the banker analyses behind each target board's recommendation.
Deals
3
Median EV / EBITDA paid
15.2x
Median EV / revenue paid
1.59x
| Announced | Target | Acquirer | Segment | EV | EV/EBITDA | EV/Rev | DCF rate | Fairness opinion |
|---|---|---|---|---|---|---|---|---|
| 2023-06-26 | Amedisys | UnitedHealth Group | Home-Based Services | $3.6B | 15.2x | 1.59x | 8.3%–10.5% | Guggenheim Securities |
| 2022-03-29 | LHC Group | UnitedHealth Group | Home-Based Services | $6.1B | 20.8x | 2.26x | 8.5%–9.5% | Leerink Partners, Jefferies |
| 2019-12-09 | Diplomat Pharmacy | UnitedHealth Group | Pharmacy / Infusion | $898M | 12.1x | 0.18x | 10.5% |